Fields »
ABOUT
HELP
BLOG

452 GENES FOUND

Show / hide columns

XML | RDF | TSV | Page of 10 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
ZNF846Zinc finger protein 846Predicted intracellular proteins
Transcription factors
Actin filamentsHead and neck cancer: 5.25e-8
Mixed
SZT2Seizure threshold 2 homolog (mouse)Disease related genes
Predicted intracellular proteins
Nucleoplasm
Vesicles
Actin filaments		Head and neck cancer: 1.47e-7
Liver cancer: 2.53e-4
Lung cancer: 6.20e-4
Expressed in all
GZMMGranzyme M (lymphocyte met-ase 1)Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Head and neck cancer: 1.87e-7
Renal cancer: 1.21e-4
Endometrial cancer: 1.89e-4
Tissue enhanced
FGD3FYVE, RhoGEF and PH domain containing 3Plasma proteins
Predicted intracellular proteins
Nucleus
Cytosol		Head and neck cancer: 2.23e-7
Cervical cancer: 5.51e-4
Tissue enhanced
PPFIA3Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3Predicted intracellular proteins
Nucleoli fibrillar center
Vesicles		Head and neck cancer: 6.46e-7
Liver cancer: 2.24e-5
Breast cancer: 3.09e-4
Endometrial cancer: 8.65e-4
Group enriched
CD27CD27 moleculeCancer-related genes
CD markers
Disease related genes
Plasma proteins
Predicted membrane proteins
Head and neck cancer: 6.65e-7
Renal cancer: 1.19e-6
Cervical cancer: 3.77e-5
Endometrial cancer: 2.90e-4
Melanoma: 5.50e-4
Tissue enhanced
JCHAINJoining chain of multimeric IgA and IgMPlasma proteins
Predicted secreted proteins
Head and neck cancer: 7.56e-7
Breast cancer: 1.81e-6
Renal cancer: 1.40e-4
Expressed in all
CCR7Chemokine (C-C motif) receptor 7Cancer-related genes
CD markers
G-protein coupled receptors
Predicted membrane proteins
MitochondriaHead and neck cancer: 7.61e-7
Cervical cancer: 8.03e-6
Breast cancer: 3.84e-4
Testis cancer: 7.72e-4
Group enriched
S1PR4Sphingosine-1-phosphate receptor 4G-protein coupled receptors
Predicted membrane proteins
MitochondriaHead and neck cancer: 1.45e-6
Cervical cancer: 1.33e-4
Endometrial cancer: 2.22e-4
Renal cancer: 2.87e-4
Breast cancer: 3.13e-4
Tissue enhanced
TNFRSF17Tumor necrosis factor receptor superfamily, member 17Cancer-related genes
CD markers
Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Head and neck cancer: 1.58e-6
Breast cancer: 1.35e-5
Tissue enhanced
IRF4Interferon regulatory factor 4Cancer-related genes
Disease related genes
Predicted intracellular proteins
Transcription factors
NucleoplasmHead and neck cancer: 1.64e-6
Breast cancer: 6.44e-4
Tissue enhanced
ZNF414Zinc finger protein 414Predicted intracellular proteins
Transcription factors
Nucleus
Cytosol		Head and neck cancer: 1.67e-6
Endometrial cancer: 4.17e-4
Pancreatic cancer: 4.59e-4
Urothelial cancer: 8.71e-4
Expressed in all
SMIM14Small integral membrane protein 14Predicted intracellular proteins
Predicted membrane proteins
MitochondriaHead and neck cancer: 3.00e-6
Renal cancer: 2.07e-4
Endometrial cancer: 2.63e-4
Liver cancer: 3.47e-4
Expressed in all
TNFRSF4Tumor necrosis factor receptor superfamily, member 4Cancer-related genes
CD markers
Disease related genes
Predicted membrane proteins
Head and neck cancer: 3.50e-6
Renal cancer: 4.52e-6
Liver cancer: 6.03e-4
Tissue enhanced
PITPNM3PITPNM family member 3Disease related genes
Predicted intracellular proteins
Plasma membraneHead and neck cancer: 3.67e-6
Tissue enhanced
ZNF557Zinc finger protein 557Predicted intracellular proteins
Transcription factors
Nucleus
Intermediate filaments
Cytosol		Head and neck cancer: 3.67e-6
Pancreatic cancer: 1.51e-4
Lung cancer: 2.62e-4
Endometrial cancer: 5.70e-4
Mixed
ZAP70Zeta-chain (TCR) associated protein kinase 70kDaDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
RAS pathway related proteins
Renal cancer: 3.02e-8
Endometrial cancer: 9.66e-8
Head and neck cancer: 3.93e-6
Cervical cancer: 6.89e-5
Tissue enhanced
ZNF266Zinc finger protein 266Predicted intracellular proteins
Transcription factors
Nucleus
Vesicles
Rods & Rings		Head and neck cancer: 3.94e-6
Pancreatic cancer: 3.03e-5
Urothelial cancer: 9.15e-5
Cervical cancer: 1.41e-4
Renal cancer: 1.82e-4
Lung cancer: 4.47e-4
Expressed in all
CLEC14AC-type lectin domain family 14, member APredicted membrane proteins
Endoplasmic reticulum
Golgi apparatus		Head and neck cancer: 4.13e-6
Tissue enhanced
CD6CD6 moleculeCD markers
Predicted membrane proteins
Predicted secreted proteins
Head and neck cancer: 5.10e-6
Cervical cancer: 1.57e-5
Renal cancer: 1.82e-4
Breast cancer: 1.95e-4
Endometrial cancer: 2.41e-4
Tissue enhanced
KDM2BLysine (K)-specific demethylase 2BEnzymes
Predicted intracellular proteins
NucleoplasmHead and neck cancer: 6.74e-6
Pancreatic cancer: 8.64e-4
Expressed in all
CD5CD5 moleculeCD markers
Predicted membrane proteins
Predicted secreted proteins
Head and neck cancer: 7.41e-6
Renal cancer: 8.94e-5
Endometrial cancer: 9.00e-5
Cervical cancer: 9.16e-5
Melanoma: 3.93e-4
Breast cancer: 4.05e-4
Tissue enhanced
ANKRD13AAnkyrin repeat domain 13APredicted intracellular proteins
Plasma membraneHead and neck cancer: 7.70e-6
Ovarian cancer: 6.77e-4
Expressed in all
PRKCHProtein kinase C, etaCancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Plasma membrane
Cytosol		Head and neck cancer: 8.55e-6
Expressed in all
TPSAB1Tryptase alpha/beta 1Enzymes
Predicted intracellular proteins
Predicted secreted proteins
Head and neck cancer: 9.62e-6
Tissue enhanced
TYK2Tyrosine kinase 2Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
CytosolHead and neck cancer: 1.05e-5
Pancreatic cancer: 1.02e-4
Urothelial cancer: 4.16e-4
Renal cancer: 4.43e-4
Endometrial cancer: 9.62e-4
Expressed in all
MMP25Matrix metallopeptidase 25Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Head and neck cancer: 1.09e-5
Tissue enhanced
CD79ACD79a molecule, immunoglobulin-associated alphaCancer-related genes
CD markers
Disease related genes
Predicted membrane proteins
Predicted secreted proteins
Head and neck cancer: 1.18e-5
Renal cancer: 2.15e-5
Breast cancer: 8.45e-5
Group enriched
CLEC10AC-type lectin domain family 10, member ACD markers
Predicted intracellular proteins
Predicted membrane proteins
Head and neck cancer: 1.26e-5
Testis cancer: 4.22e-4
Lung cancer: 9.24e-4
Mixed
FCGBPFc fragment of IgG binding proteinPredicted intracellular proteins
Predicted secreted proteins
Golgi apparatus
Plasma membrane
Cytokinetic bridge		Ovarian cancer: 9.70e-6
Head and neck cancer: 1.28e-5
Liver cancer: 4.74e-5
Thyroid cancer: 4.27e-4
Tissue enhanced
PAOXPolyamine oxidase (exo-N4-amino)Enzymes
Predicted intracellular proteins
Nucleoplasm
Centrosome		Head and neck cancer: 1.38e-5
Cervical cancer: 6.07e-5
Renal cancer: 9.49e-4
Tissue enhanced
RASGEF1BRasGEF domain family, member 1BPredicted intracellular proteins
NucleusRenal cancer: 4.21e-6
Head and neck cancer: 1.49e-5
Cervical cancer: 6.40e-4
Mixed
NR2C2Nuclear receptor subfamily 2, group C, member 2Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Transcription factors
NucleoplasmHead and neck cancer: 1.51e-5
Expressed in all
SH3BP2SH3-domain binding protein 2Disease related genes
Plasma proteins
Predicted intracellular proteins
Nucleus
Actin filaments		Endometrial cancer: 5.42e-6
Head and neck cancer: 1.57e-5
Urothelial cancer: 2.67e-4
Expressed in all
CD164L2CD164 sialomucin-like 2Predicted membrane proteins
Head and neck cancer: 1.64e-5
Tissue enhanced
FAM65CFamily with sequence similarity 65, member CPredicted intracellular proteins
NucleoplasmHead and neck cancer: 1.66e-5
Mixed
ITPKBInositol-trisphosphate 3-kinase BCancer-related genes
Enzymes
Predicted intracellular proteins
NucleusHead and neck cancer: 1.72e-5
Lung cancer: 6.65e-4
Expressed in all
WDR37WD repeat domain 37Predicted intracellular proteins
Intermediate filaments
Centrosome
Cytosol		Pancreatic cancer: 1.46e-6
Thyroid cancer: 1.34e-5
Head and neck cancer: 1.75e-5
Expressed in all
AQP5Aquaporin 5Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Plasma membraneHead and neck cancer: 1.75e-5
Group enriched
TBC1D10CTBC1 domain family, member 10CPredicted intracellular proteins
Predicted membrane proteins
Nuclear bodiesRenal cancer: 4.35e-7
Head and neck cancer: 1.86e-5
Breast cancer: 3.83e-4
Cervical cancer: 4.20e-4
Tissue enhanced
ANKRD29Ankyrin repeat domain 29Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Nuclear bodies		Head and neck cancer: 1.92e-5
Lung cancer: 5.98e-5
Renal cancer: 7.20e-5
Mixed
SPOCK2Sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2Predicted secreted proteins
Nuclear specklesHead and neck cancer: 1.95e-5
Breast cancer: 4.05e-4
Melanoma: 4.72e-4
Ovarian cancer: 7.19e-4
Tissue enhanced
INPP5DInositol polyphosphate-5-phosphatase DEnzymes
Plasma proteins
Predicted intracellular proteins
CytosolHead and neck cancer: 2.03e-5
Mixed
SPIBSpi-B transcription factor (Spi-1/PU.1 related)Predicted intracellular proteins
Transcription factors
Head and neck cancer: 2.14e-5
Breast cancer: 4.76e-5
Tissue enhanced
GNG8Guanine nucleotide binding protein (G protein), gamma 8Predicted intracellular proteins
RAS pathway related proteins
Head and neck cancer: 2.14e-5
Tissue enhanced
MXD4MAX dimerization protein 4Predicted intracellular proteins
Transcription factors
CytosolPancreatic cancer: 1.39e-5
Head and neck cancer: 2.21e-5
Expressed in all
EPHX3Epoxide hydrolase 3Predicted secreted proteins
Head and neck cancer: 2.27e-5
Group enriched
IL20RAInterleukin 20 receptor, alphaPredicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
CytosolEndometrial cancer: 1.43e-6
Head and neck cancer: 2.29e-5
Tissue enhanced
CUL9Cullin 9Plasma proteins
Predicted intracellular proteins
CytosolHead and neck cancer: 2.37e-5
Colorectal cancer: 2.48e-4
Urothelial cancer: 4.87e-4
Breast cancer: 5.28e-4
Pancreatic cancer: 8.07e-4
Mixed
OSR2Odd-skipped related transciption factor 2Predicted intracellular proteins
Transcription factors
Nucleus
Plasma membrane		Head and neck cancer: 2.44e-5
Tissue enhanced

Page of 10 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.